Literature DB >> 900084

Reliability of salivary theophylline as a guide to plasma theophylline levels.

S P Galant, S A Gillman, L H Cummins, P P Kozak, J J Orcutt.   

Abstract

Simultaneous saliva and plasma theophylline levels in 12 chronic asthmatic children were measured by high pressure liquid chromatography following administration of a theophylline preparation. In five subjects, simultaneous plasma and salivary theophylline were measured one week later. A strongly positive correlation between plasma and salivary theophylline levels was found at all time periods tested. There was no substantial difference in the plasma-saliva theophylline ratio determined one week later. A predicted plasma level was compared with the observed value. The proportionality of predicted to observed plasma theophylline levels using either the entire study group mean plasma-saliva ratio or each individual's ratio was approximately 1.00 with 9% variability. When a previously reported plasma-saliva theophylline ratio was used for comparison, the predicted plasma theophylline was 15% above the observed plasma level.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 900084     DOI: 10.1001/archpedi.1977.02120220036004

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  8 in total

1.  Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.

Authors:  C Knott; M Bateman; F Reynolds
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

2.  Salivary and urine theophylline levels in management of childhood asthma.

Authors:  S J Goldsworthy; M Kemp; J O Warner
Journal:  J R Soc Med       Date:  1981-06       Impact factor: 5.344

3.  Proceeding of the British Pharmacological Society, Clinical Pharmacology Section, 16-18th December, 1980, University of London. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

4.  Evaluation of the absorption from 15 commercial theophylline products indicating deficiencies in currently applied bioavailability criteria.

Authors:  R A Upton; L Sansom; T W Guentert; J R Powell; J F Thiercelin; V P Shah; P E Coates; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1980-06

5.  Zero-order rectal delivery of theophylline in man with an osmotic system.

Authors:  L G de Leede; A G de Boer; S L van Velzen; D D Breimer
Journal:  J Pharmacokinet Biopharm       Date:  1982-10

6.  Reproducibility of saliva and plasma theophylline levels following single dose administration of two sustained release preparations.

Authors:  A H Jackson; C Edwards; A S Cope; R A Stockley; R Purkiss
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

7.  Evaluation of the absorption from some commercial sustained-release theophylline products.

Authors:  R A Upton; J F Thiercelin; T W Guentert; L Sansom; J R Powell; P E Coates; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1980-04

8.  Correlation of serum and saliva theophylline concentration after administration of a sustained release preparation.

Authors:  J H Jonkman; G H Koëter; R Schoenmaker; K de Vries; J E Greving; R A de Zeeuw
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.